Lifestyle influences up to half your cancer risk

In this interview, M3-Principal Investigator Dr. Lukas Mager discusses the current state of research on the relationship between the gut microbiome and cancer. Studies indicate that specific microbial patterns are associated with cancer, and that the composition of the microbiome can influence how patients respond to cancer treatments.

While these findings are promising, microbiome-based diagnostics and therapies are still under development. Routine microbiome testing for cancer screening is not currently recommended but may play a complementary role in the future as research advances.

Lifestyle factors, such as diet, physical activity, alcohol consumption and smoking remain the key determinants of cancer risk and also support a healthy microbiome. 

Read the full article here (German):

https://www.medpertise.de/mikrobiom/interview/mikrobiom-krebs-einfluss-lebensstil-dr-lukas-mager/